209 related articles for article (PubMed ID: 31773752)
21. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.
Moura Filho JP; Peixoto RL; Martins LG; Melo SD; Carvalho LL; Pereira AK; Freire EA
An Bras Dermatol; 2014; 89(1):118-25. PubMed ID: 24626656
[TBL] [Abstract][Full Text] [Related]
22. Keratinocyte and lymphocyte apoptosis: relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations.
Salem SA; Farouk HM; Mostafa AA; Hassan IM; Osman WM; Al-Shamy HA; Assaf NY
Eur J Dermatol; 2010; 20(1):35-41. PubMed ID: 19919906
[TBL] [Abstract][Full Text] [Related]
23. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
[TBL] [Abstract][Full Text] [Related]
24. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
Chlebus E; Wolska H; Blaszczyk M; Jablonska S
J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
[TBL] [Abstract][Full Text] [Related]
25. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.
Bae EH; Lim SY; Han KD; Jung JH; Choi HS; Kim CS; Ma SK; Kim SW
Lupus; 2019 Mar; 28(3):317-323. PubMed ID: 30712493
[TBL] [Abstract][Full Text] [Related]
26. Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis.
Darba J; Ascanio M; Agüera A
Orphanet J Rare Dis; 2024 Feb; 19(1):74. PubMed ID: 38365713
[TBL] [Abstract][Full Text] [Related]
27. Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus.
Vital EM; Wittmann M; Edward S; Md Yusof MY; MacIver H; Pease CT; Goodfield M; Emery P
Arthritis Rheumatol; 2015 Jun; 67(6):1586-91. PubMed ID: 25707733
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.
Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR
Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985
[TBL] [Abstract][Full Text] [Related]
29. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A
JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672
[TBL] [Abstract][Full Text] [Related]
30. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients.
Watanabe T; Tsuchida T
Dermatology; 1995; 190(4):277-83. PubMed ID: 7655105
[TBL] [Abstract][Full Text] [Related]
31. Distinguishing subacute cutaneous from other types of lupus erythematosus.
McCauliffe DP
Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
[No Abstract] [Full Text] [Related]
32. Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study.
Hamed HO; Ahmed SR; Alzolibani A; Kamal MM; Mostafa MS; Gamal RM; Atallah DA; Abd-El-Aall DE
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):934-42. PubMed ID: 23621378
[TBL] [Abstract][Full Text] [Related]
33. [Simultaneous occurrence of lupus erythematosus and desquamative interstitial alveolitis].
Remenyik E; Mészáros C; Vezendi S; Dankó K
Orv Hetil; 1990 Sep; 131(37):2043-5. PubMed ID: 2216432
[TBL] [Abstract][Full Text] [Related]
34. Histologic features of cutaneous lupus erythematosus.
Baltaci M; Fritsch P
Autoimmun Rev; 2009 May; 8(6):467-73. PubMed ID: 19162243
[TBL] [Abstract][Full Text] [Related]
35. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of pediatric cutaneous lupus erythematosus: experience from a tertiary referral center in Korea.
Lee SK; Baek J; Roh JY; Kim HJ
Lupus; 2019 Jun; 28(7):888-892. PubMed ID: 31112454
[TBL] [Abstract][Full Text] [Related]
37. Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients.
Böckle BC; Sepp NT
Lupus; 2015 Jun; 24(7):669-74. PubMed ID: 25411260
[TBL] [Abstract][Full Text] [Related]
38. [Erythema elevatum diutinum--a rare variant of skin changes in systemic lupus erythematosus].
Schulze P; Audring H; Sönnichsen N
Dermatol Monatsschr; 1989; 175(10):628-34. PubMed ID: 2591614
[TBL] [Abstract][Full Text] [Related]
39. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
Tiao J; Feng R; Carr K; Okawa J; Werth VP
J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
[TBL] [Abstract][Full Text] [Related]
40. Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl.
Tincopa M; Puttgen KB; Sule S; Cohen BA; Gerstenblith MR
Pediatr Dermatol; 2010; 27(4):373-6. PubMed ID: 20653856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
